Program Description: 

The Medical College of Wisconsin (MCW) has a mission to be the national leader in providing high quality healthcare. One of the ways that we are doing this is to provide high quality continuing medical education (CME) to our faculty; this includes presentation from national leaders in the field of Nephrology. Our education al topics focus on outcomes research in chronic kidney disease and end-stage renal disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard of care, continuing review of kidney biopsy pathology, and basic science research that may become future therapeutics.

 
 
ACCME Accreditation Statement:        
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 
  • Physicians
  • Physicians Assistants
  • Nurse/Nurse Practitioners
  • Medical Students
Learning objectives: 
  1. Continuing education presentations will include the pathogenesis, diagnoses, and treatment of kidney diseases including but not limited to the following conditions of: hypertension, chronic kidney disease, acute kidney injury, kidney transplant and immunosuppression, glomerulonephritis, nephrotic syndrome, electrolytes disorders and metabolic acidosis and alkalosis.
  2. Attendees will be expected to critically evaluate advances in the field of Nephrology by reviewing studies such as SPRINT for HTN1,4 and improvement in immunosuppression for kidney transplant.6 These studies demonstrate safe and effective treatments for kidney related disease and compare outcomes to current standard of care so that clinical practice can be improved. 
  3. Apply newly obtained clinical knowledge to enhance patient care in Nephrology and use this new knowledge to create quality indicators such as control of BP in the CKD population and length of kidney transplant graft survival. These quality indicators can be used monitored to evaluate for performance below national levels (the standard) that would indicate specific areas for improvement.
Faculty & credentials: 
Planning Team Members:
Dawn Wolfgram, MD
Kevin Regner, MD
 
 

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):


In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Carriann Horstead
Phone number: 
+1 (414) 805-9050
Series date: 
Monday, January 1, 2018 - 8:00am to Monday, December 31, 2018 - 12:15am
Series location: 
Hub for Collaborative Medicine
8701 Watertown Plank Rd
HUB, 7th Floor, Room A7520/A7628
Milwaukee, WI , WI 53226
United States

Sessions

Session Datesort descending
18056 ApoL1 Nephropathy, January 16, 2018 01/16/2018 - 4:00pm to 5:00pm
18056 Biopsy Conference - January 23, 2018 01/23/2018 - 4:00pm to 5:00pm
18056 Kidney Transplant from Pediatric Donors Less than 5 Years of Age En Bloc vs Single Kidney Transplant - January 30, 2018 01/30/2018 - 4:00pm to 5:00pm
18056 Sodium Dependent and Independent Mechanisms of Hypertensive Kidney Damage - February 6, 2018 02/06/2018 - 4:00pm to 5:00pm
18056 Intradialytic Cerebral Perfusion and Cognitive Outcomes - February 13, 2018 02/13/2018 - 4:00pm to 5:00pm
18056 Lifestyle Interventions to Delay Diabetic Kidney Disease in African Americans with T2DM - February 20, 2018 02/20/2018 - 4:00pm to 5:00pm
18056 Nephrology Biopsy Conference - February 27, 2018 02/27/2018 - 4:00pm to 5:00pm
18056 Endocrine Hypertension - March 6, 2018 03/06/2018 - 4:00pm to 5:00pm
18056 Challanges In Diagnosing and Treating Heptorenal Syndrome - March 13, 2018 03/13/2018 - 4:00pm to 5:00pm
18056 Do Genes Matter in Acute Kidney Injury? - March 20, 2018 03/20/2018 - 4:00pm to 5:00pm
18056 Nephrology Biopsy Conference - March 27, 2018 03/27/2018 - 4:00pm to 5:00pm
18056 Risk and Benefits of Bariatric Surgery in Morbidly Obese ESRD Patients Eligible for Kidney Transplantation - April 3, 2018 04/03/2018 - 4:00pm to 5:00pm
18056 Calcium Channels and Proteinuric Renal Disease - April 10, 2018 04/10/2018 - 4:00pm to 5:00pm
18056 Renal Autoantibodies: A Decade of Discovery--April 24, 2018 04/24/2018 - 4:00pm to 5:00pm
18056 Nephrology Biopsy Conference - May 1, 2018 05/01/2018 - 4:00pm to 5:00pm
18056 Lessons from the United States Renal Data System - May 8, 2018 05/08/2018 - 4:00pm to 5:00pm
18056 Urinary Exosomal Expression of Activator of G Protein Signaling 3 in Polycycstic Kidney Disease - May 15, 2018 05/15/2018 - 4:00pm to 5:00pm
18056 The Role of EGF Receptor in Kidney Injury - May 22, 2018 05/22/2018 - 4:00pm to 5:00pm
18056 The Interface Between Palliative Care and Nephrology: Striving for Patient-Centered Care - May 29, 2018 05/29/2018 - 4:00pm to 5:00pm
18056 Plasma Cell Disorders Following Renal Transplantation: A Retrospective Analysis - June 5, 2018 06/05/2018 - 4:00pm to 5:00pm
18056 Effect of Bariatric Surgery on CKD Risk - June 12, 2018 06/12/2018 - 4:00pm to 5:00pm
18056 M & M Conference - June 19, 2018 06/19/2018 - 4:00pm to 5:00pm
18056 Fellows QI Project - June 26, 2018 06/26/2018 - 4:00pm to 5:00pm
18056 Biopsy Conference - July 17, 2018 07/17/2018 - 3:30pm to 4:30pm
18056 CKD-MBD After Renal Transplantation, What is Hot What is New! - July 24, 2018 07/24/2018 - 3:30pm to 4:30pm
18056 Inactivation of p66Shc Decreases Afferent Arteriolar Katp Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats - July 31, 2018 07/31/2018 - 3:30pm to 4:30pm
18056 Banff Classification of Polyoma Virus Nephropathy - August 14, 2018 08/14/2018 - 3:30pm to 4:30pm
18056 Biopsy Conference - August 21, 2018 08/21/2018 - 3:30pm to 4:30pm
18056 Stone Matrix Proteomics Update--Lessons from Different Stone Types - August 28, 2018 08/28/2018 - 3:30pm to 4:30pm
18056 - Cell-Free DNA and Active Rejection in Kidney Allografts - September 4, 2018 09/04/2018 - 3:30pm to 4:30pm